Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Allergan Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Allergan Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Allergan Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Allergan Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
Allergan Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Allergan Plc, Medical Equipment, Deal Details 17
Asset Purchase 17
Allergan Acquires Rights to LiRIS from TARIS Biomedical for USD588 Million 17
Allergan Acquires Aline Hyaluronic Acid Thread Technology From Aline Aesthetics 18
LifeCell Acquires Adipose Tissue Injector From TauTona 19
Venture Financing 20
ForSight Vision5 Raises Additional USD4 Million Financingc 20
ForSight Vision5 Raises Additional USD6 Million in Financing 21
Colorescience Raises USD15 Million in Series B Venture Financing 22
ForSight Vision5 Raises US$15 Million In Series C Financing 23
Oculeve Raises US$17 Million In Venture Financing 24
AqueSys Raises US$43.6 Million In Series D Financing 25
Colorescience Raises US$10 Million In Series A Financing 27
ForSight Vision5 Raises US$9 Million In Series B-1 Financing 28
Anterios Raises US$8.5 Million In Venture Financing 29
Anterios Raises US$4.7 Million In Venture Financing 30
Oculeve Raises US$7.6 Million In Venture Financing 31
Topokine Therapeutics Raises Funds Through Venture Financing 32
Colorescience Raises US$15 Million In Venture Financing 33
Regado Biosciences Raises US$51 Million In Series E Financing 34
Oculeve Raises Additional US$0.2 Million In Venture Financing 36
ForSight Vision5 Raises US$8 Million In Venture Financing 37
Uteron Pharma Raises US$10.4 Million In Venture Financing 38
AqueSys Raises US$12 Million In Venture Financing 39
Uteron Pharma Raises US$19 Million In Venture Financing 40
KYTHERA BioPharma Secures US$37.42 Million In Series D Financing Round 41
Anterios Secures US$3.1 Million In Venture Financing 43
Regado Biosciences Secures US$11.6 Million In Financing 44
ForSight Vision5 Raises US$6 Million In Venture Financing 45
Private Equity 46
TPG Capital Acquires Aptalis Pharma from Actavis 46
VMG Partners Invests In Colorescience 47
SRIW Invests US$2 Million In Uteron Pharma 48
Partnerships 49
Medicines360 Enters Into Licensing Agreement With Actavis For Intrauterine Device 49
Enzymatica To Enter Into Licensing Agreement With Actavis For ColdZyme Mouth Spray 50
T2 Biosystems Enters into Agreement with Allergan 51
Allergan Enters into Co-Development Agreement with SonarMD 52
Syneron Medical and Allergan Enter into Agreement 53
Galderma Enters into Agreement with ZELTIQ Aesthetics 54
Advance Medical Enters Into Co-Marketing Agreement With Zeltiq Aesthetics For CoolSculpting System 55
Activaero Enters Into Collaboration With Forest Healthcare 56
Equity Offering 57
Anterios Postpones IPO for up to USD54.6 Million 57
Actavis Raises USD5.06 Billion in Public Offering of Preferred Shares 58
Actavis Raises USD4.18 Billion in Public Offering of Shares 60
Regado Biosciences Completes Public Offering Of Shares For US$60 Million 62
Regado Biosciences Completes Private Placement Of Shares For US$20 Million 63
Regado Biosciences Completes Underwriters’ Exercise Of Over-Allotment Option For IPO For US$43 Million 64
Zeltiq Aesthetics Files Registration Statement For Public Offering Of Securities For US$75 Million 66
Forest Labs Plans Rights Offering Of Common Stock 67
ZELTIQ Aesthetics Completes IPO For US$101 Million 68
Debt Offering 70
Allergan Raises USD599.7 Million in Public Offering of 2.125% Notes Due 2029 70
Allergan Raises USD763.3 Million in Public Offering of Notes Due 2019 71
Allergan Raises USD763.3 Million in Public Offering of 1.25% Notes Due 2024 72
Forest Lab Completes Private Placement Of Notes Due 2019 For US$1.05 Billion 73
Forest Lab Completes Private Placement Of Notes Due 2021 For US$750 Million 74
Forest Labs Completes Private Placement Of Notes Due 2021 For US$1.2 Billion 75
Asset Transactions 76
Novadaq to Acquire Rights to SPY Elite System from LifeCell 76
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 77
Acquisition 79
Allergan to Sell 10% Stake in Teva Pharma 79
Allergan Sales to Acquire Keller Medical 80
Allergan Acquires ZELTIQ Aesthetics for USD2.48 Billion 81
Allergan Acquires LifeCell from Acelity for USD2.9 Billion 83
Allergan Acquires Tobira Therapeutics in Tender Offer 85
Carl Icahn Acquires Stake in Allergan 87
Allergan Acquires AqueSys 88
Allergan Acquires Northwood Medical 89
Allergan Acquires Oculeve 90
Actavis Acquires Allergan for USD70.5 Billion 91
Actavis Completes Acquisition of Forest Labs for USD28 Billion 93
Forest Lab Completes Acquisition Of Aptalis Pharma From TPG Capital For US$2.9 Billion 95
AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion 97
Actavis Completes Acquisition Of Remaining 26.7% Stake In Zdravlje For Up To US$9.1 Million 98
Watson Pharma Acquires Uteron Pharma, Women’s Health Company, For Up To US$305 Million 99
SkinMedica Acquires Colorescience, Maker Of Skincare Products 101
Allergan Acquires Precision Light For US$17.9 Million 102
Allergan Completes Acquisition Of Alacer Biomedical 103
Forest Labs Completes Acquisition Of Clinical Data 104
Allergan Plc – Key Competitors 106
Allergan Plc – Key Employees 107
Allergan Plc – Locations And Subsidiaries 108
Head Office 108
Other Locations & Subsidiaries 108
Recent Developments 116
Strategy And Business Planning 116
Aug 09, 2016: EDA Board Acts to Encourage Global Pharmaceutical Company Allergan to Expand in New Jersey 116
Financial Announcements 117
Nov 01, 2017: Allergan Reports Solid Top-Line Execution in Third Quarter 2017 with 11% Increase in GAAP Net Revenues to $4.03 Billion 117
Aug 03, 2017: Allergan Reports Continued Strong Execution in Second Quarter 2017 with 9% Increase in GAAP Net Revenues to $4.0 Billion 121
May 09, 2017: Allergan Reports Solid Start to 2017 with 5% Increase in First Quarter GAAP Net Revenues to $3.6 Billion 125
Feb 08, 2017: Allergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016 129
Nov 02, 2016: Allergan Reports Third Quarter 2016 Continuing Operations Performance with GAAP Net Revenues of $3.6 Billion; Announces Accelerated Share Repurchase, Initiation of Cash Dividend 133
Aug 08, 2016: Allergan Reports Strong Second Quarter 2016 Continuing Operations Performance with Net Revenues of $3.7 Billion 137
May 10, 2016: Allergan Reports Strong First Quarter 2016 Continuing Operations Performance with 48% Increase in Net Revenue to $3.8 Billion and 15% Growth in Non-GAAP Diluted EPS to $3.04 141
Corporate Communications 144
Dec 18, 2017: Allergan Announces Promotion of Wayne Swanton to Executive Vice President, Global Operations 144
Sep 11, 2017: The Allergan Foundation to Donate $150,000 to Support Hurricane Irma Relief Efforts 145
Jul 19, 2017: Joseph H. Boccuzi Appointed to Allergan Board of Directors 146
Apr 10, 2017: Allergan Receives 2017 ENERGY STAR Partner of the Year – Sustained Excellence Award from U.S. Environmental Protection Agency 147
Apr 06, 2017: Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy 148
Feb 27, 2017: Lisa DeFrancesco, Vice President of Investor Relations, to Leave Allergan 149
Nov 14, 2016: Adriane M. Brown to Join Allergan Board of Directors 150
Oct 26, 2016: Allergan Announces Changes to Board Leadership 151
Feb 08, 2016: Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction 152
Product News 153
Nov 08, 2017: Allergan to Present Dynamic Eye Care Data at American Academy of Ophthalmology Meeting in New Orleans 153
Oct 11, 2017: Allergan to Present Data From More Than 20 Abstracts at the 2017 Fall Clinical Dermatology Conference 154
Oct 05, 2017: Allergan Presents Data From Seventeen Abstracts At The 2017 American Society For Dermatologic Surgery Meeting In Chicago 155
May 04, 2017: Allergan to Present New Data at the 2017 American College of Obstetricians and Gynecologists (ACOG) Clinical and Scientific Meeting in San Diego 157
Jan 05, 2017: Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Outlook 158
May 04, 2016: Allergan Presents Data at the 2016 American Society of Cataract and Refractive Surgery Symposium & Congress in New Orleans 159
03/03/2016: Allergan Launches Bold Access To LILETTA (levonorgestrel-releasing intrauterine system) 160
Other Significant Developments 161
Sep 25, 2017: New Study Showcases Economic Impact of Allergan Operations on French Economy 161
Sep 14, 2017: Industry Leaders Allergan and Sientra Invest in The American Society for Aesthetic Plastic Surgery for Breast Implant Research 162
Sep 12, 2017: Allergan Launches New Brilliant Distinctions Patient Loyalty Program 163
Oct 13, 2016: Allergan Partners with SonarMD to Develop Innovative IBS-D Patient Engagement Platform for Better Identification and Care of IBS-D Patients 164
Oct 05, 2016: New Study Showcases Economic Impact of Allergan’s Operations on New Jersey Economy 165
Appendix 167
Methodology 167
About GlobalData 167
Contact Us 167
Disclaimer 167
Allergan Plc, Medical Equipment, Key Facts, 2016 2
Allergan Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Allergan Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Allergan Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Allergan Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Allergan Plc, Deals By Market, 2011 to YTD 2017 11
Allergan Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Allergan Acquires Rights to LiRIS from TARIS Biomedical for USD588 Million 17
Allergan Acquires Aline Hyaluronic Acid Thread Technology From Aline Aesthetics 18
LifeCell Acquires Adipose Tissue Injector From TauTona 19
ForSight Vision5 Raises Additional USD4 Million Financingc 20
ForSight Vision5 Raises Additional USD6 Million in Financing 21
Colorescience Raises USD15 Million in Series B Venture Financing 22
ForSight Vision5 Raises US$15 Million In Series C Financing 23
Oculeve Raises US$17 Million In Venture Financing 24
AqueSys Raises US$43.6 Million In Series D Financing 25
Colorescience Raises US$10 Million In Series A Financing 27
ForSight Vision5 Raises US$9 Million In Series B-1 Financing 28
Anterios Raises US$8.5 Million In Venture Financing 29
Anterios Raises US$4.7 Million In Venture Financing 30
Oculeve Raises US$7.6 Million In Venture Financing 31
Topokine Therapeutics Raises Funds Through Venture Financing 32
Colorescience Raises US$15 Million In Venture Financing 33
Regado Biosciences Raises US$51 Million In Series E Financing 34
Oculeve Raises Additional US$0.2 Million In Venture Financing 36
ForSight Vision5 Raises US$8 Million In Venture Financing 37
Uteron Pharma Raises US$10.4 Million In Venture Financing 38
AqueSys Raises US$12 Million In Venture Financing 39
Uteron Pharma Raises US$19 Million In Venture Financing 40
KYTHERA BioPharma Secures US$37.42 Million In Series D Financing Round 41
Anterios Secures US$3.1 Million In Venture Financing 43
Regado Biosciences Secures US$11.6 Million In Financing 44
ForSight Vision5 Raises US$6 Million In Venture Financing 45
TPG Capital Acquires Aptalis Pharma from Actavis 46
VMG Partners Invests In Colorescience 47
SRIW Invests US$2 Million In Uteron Pharma 48
Medicines360 Enters Into Licensing Agreement With Actavis For Intrauterine Device 49
Enzymatica To Enter Into Licensing Agreement With Actavis For ColdZyme Mouth Spray 50
T2 Biosystems Enters into Agreement with Allergan 51
Allergan Enters into Co-Development Agreement with SonarMD 52
Syneron Medical and Allergan Enter into Agreement 53
Galderma Enters into Agreement with ZELTIQ Aesthetics 54
Advance Medical Enters Into Co-Marketing Agreement With Zeltiq Aesthetics For CoolSculpting System 55
Activaero Enters Into Collaboration With Forest Healthcare 56
Anterios Postpones IPO for up to USD54.6 Million 57
Actavis Raises USD5.06 Billion in Public Offering of Preferred Shares 58
Actavis Raises USD4.18 Billion in Public Offering of Shares 60
Regado Biosciences Completes Public Offering Of Shares For US$60 Million 62
Regado Biosciences Completes Private Placement Of Shares For US$20 Million 63
Regado Biosciences Completes Underwriters' Exercise Of Over-Allotment Option For IPO For US$43 Million 64
Zeltiq Aesthetics Files Registration Statement For Public Offering Of Securities For US$75 Million 66
Forest Labs Plans Rights Offering Of Common Stock 67
ZELTIQ Aesthetics Completes IPO For US$101 Million 68
Allergan Raises USD599.7 Million in Public Offering of 2.125% Notes Due 2029 70
Allergan Raises USD763.3 Million in Public Offering of Notes Due 2019 71
Allergan Raises USD763.3 Million in Public Offering of 1.25% Notes Due 2024 72
Forest Lab Completes Private Placement Of Notes Due 2019 For US$1.05 Billion 73
Forest Lab Completes Private Placement Of Notes Due 2021 For US$750 Million 74
Forest Labs Completes Private Placement Of Notes Due 2021 For US$1.2 Billion 75
Novadaq to Acquire Rights to SPY Elite System from LifeCell 76
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 77
Allergan to Sell 10% Stake in Teva Pharma 79
Allergan Sales to Acquire Keller Medical 80
Allergan Acquires ZELTIQ Aesthetics for USD2.48 Billion 81
Allergan Acquires LifeCell from Acelity for USD2.9 Billion 83
Allergan Acquires Tobira Therapeutics in Tender Offer 85
Carl Icahn Acquires Stake in Allergan 87
Allergan Acquires AqueSys 88
Allergan Acquires Northwood Medical 89
Allergan Acquires Oculeve 90
Actavis Acquires Allergan for USD70.5 Billion 91
Actavis Completes Acquisition of Forest Labs for USD28 Billion 93
Forest Lab Completes Acquisition Of Aptalis Pharma From TPG Capital For US$2.9 Billion 95
AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion 97
Actavis Completes Acquisition Of Remaining 26.7% Stake In Zdravlje For Up To US$9.1 Million 98
Watson Pharma Acquires Uteron Pharma, Women's Health Company, For Up To US$305 Million 99
SkinMedica Acquires Colorescience, Maker Of Skincare Products 101
Allergan Acquires Precision Light For US$17.9 Million 102
Allergan Completes Acquisition Of Alacer Biomedical 103
Forest Labs Completes Acquisition Of Clinical Data 104
Allergan Plc, Key Competitors 106
Allergan Plc, Key Employees 107
Allergan Plc, Other Locations 108
Allergan Plc, Subsidiaries 108